Literature DB >> 12047023

The schizophrenia PORT pharmacological treatment recommendations: conformance and implications for symptoms and functional outcome.

Robert W Buchanan1, Julie Kreyenbuhl, Julie M Zito, Anthony Lehman.   

Abstract

This cross-sectional study examines conformance to four of the Schizophrenia Patient Outcomes Research Team (PORT) antipsychotic treatment recommendations, patient and treatment setting characteristics assocated with conformance, and the relationship of conformance with outcome. Two hundred twenty-four inpatients and 358 outpatients with schizophrenia underwent an interview and review of their medical records. Demographic, clinical, and role function data were collected. Almost all inpatients and outpatients with schizophrenia or schizoaffective disorder were prescribed an antipsychotic. The majority of inpatients were prescribed an antipsychotic within the recommended dose range, whereas the majority of outpatients were prescribed an antipsychotic either below or above the recommended dose range. There were no consistent relationships between patient, geographic, and treatment characteristics and antipsychotic dose. Patients treated with conventional antipsychotic doses below the recommended dose range had significantly better role function. Prospective longitudinal studies are required to delineate the factors that may underlie this relationship.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12047023     DOI: 10.1093/oxfordjournals.schbul.a006927

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  7 in total

1.  Clinical improvement associated with conformance to HEDIS-based depression care.

Authors:  Kathryn Rost; L Miriam Dickinson; John Fortney; John Westfall; Richard C Hermann
Journal:  Ment Health Serv Res       Date:  2005-06

2.  A conditional model of evidence-based decision making.

Authors:  Paul R Falzer; Melissa D Garman
Journal:  J Eval Clin Pract       Date:  2009-12       Impact factor: 2.431

3.  Adherence of psychopharmacological prescriptions to clinical practice guidelines in patients with eating behavior disorders.

Authors:  María Del Mar Alañón Pardo; Mónica Ferrit Martín; Miguel Ángel Calleja Hernández; Francisco Morillas Márquez
Journal:  Eur J Clin Pharmacol       Date:  2017-06-26       Impact factor: 2.953

4.  [Guideline conformity and outcome of inpatient treatment for schizophrenia. A clinical comparison].

Authors:  B Janssen; S Weinmann; M Berger; M Härter; T Held; M Leipert; H J Luderer; M Schwarz; T Steinert; W Gaebel
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

5.  Changes over time and disparities in schizophrenia treatment quality.

Authors:  Alisa B Busch; Anthony F Lehman; Howard Goldman; Richard G Frank
Journal:  Med Care       Date:  2009-02       Impact factor: 2.983

6.  Community adherence to schizophrenia treatment and safety monitoring guidelines.

Authors:  William R Keller; Bernard A Fischer; Robert McMahon; Walter Meyer; Melissa Blake; Robert W Buchanan
Journal:  J Nerv Ment Dis       Date:  2014-01       Impact factor: 2.254

7.  Incorporating clinical guidelines through clinician decision-making.

Authors:  Paul R Falzer; Brent A Moore; D Melissa Garman
Journal:  Implement Sci       Date:  2008-02-29       Impact factor: 7.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.